Teleflex Incorporated $TFX Shares Sold by Cooke & Bieler LP

by · The Markets Daily

Cooke & Bieler LP trimmed its holdings in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 11.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 900,561 shares of the medical technology company’s stock after selling 111,105 shares during the period. Teleflex comprises about 1.7% of Cooke & Bieler LP’s portfolio, making the stock its 18th largest position. Cooke & Bieler LP owned approximately 2.13% of Teleflex worth $112,606,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TFX. BlackRock Inc. bought a new stake in shares of Teleflex in the 2nd quarter valued at about $688,537,000. Jupiter Topco LLC purchased a new stake in shares of Teleflex in the 2nd quarter worth approximately $550,456,000. Janus Henderson Group PLC lifted its position in shares of Teleflex by 1.1% in the 1st quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock worth $513,281,000 after purchasing an additional 45,199 shares during the period. Irenic Capital Management LP purchased a new stake in shares of Teleflex in the 1st quarter worth approximately $104,061,000. Finally, Pzena Investment Management LLC boosted its stake in shares of Teleflex by 84.2% during the first quarter. Pzena Investment Management LLC now owns 699,125 shares of the medical technology company’s stock valued at $83,622,000 after purchasing an additional 319,660 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. BMO Capital Markets assumed coverage on shares of Teleflex in a report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Truist Financial reduced their price objective on shares of Teleflex from $150.00 to $142.00 and set a “hold” rating for the company in a research note on Wednesday, October 14th. Mizuho upped their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Needham & Company LLC increased their target price on Teleflex from $159.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, August 25th. Finally, Bank of America raised Teleflex from a “neutral” rating to a “buy” rating and increased their target price for the company from $145.00 to $158.00 in a research report on Monday, September 28th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $154.40.

Check Out Our Latest Analysis on Teleflex

Teleflex Stock Performance

Shares of Teleflex stock opened at $130.47 on Thursday. The company has a market capitalization of $5.53 billion, a PE ratio of -5.60, a P/E/G ratio of 0.88 and a beta of 0.83. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The company has a 50-day simple moving average of $130.95 and a two-hundred day simple moving average of $130.62. Teleflex Incorporated has a one year low of $100.18 and a one year high of $145.00.

Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The business had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. During the same period in the prior year, the firm posted $3.73 earnings per share. The company’s quarterly revenue was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Research analysts expect that Teleflex Incorporated will post 7.22 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Friday, August 14th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, August 14th. Teleflex’s payout ratio is -5.84%.

Teleflex Profile

(Free Report)

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.

Further Reading